|
1996 |
|
|
|
Kushimoto S, Okajima K, Okabe H, Binder BR. Role of granulocyte elastase in the formation of hemmorrhagic shock-induced gastric mucosal lesions in the rat. Crit Care Med. 1996, Vol. 24(6), p1041-1046. |
|
Addo Boadu K, Wojta J, Christ G, Hufnagl P, Pehamberger H, Binder BR. Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro. Cancer Lett. 1996, Vol. 103(2), p125-129. |
|
Kapetanopoulos A, Vanhove B, Bach FH, deMartin R. Localization of the human Mitogen-Induced GTP-Binding Protein Gem to Chromosome 8q22.3. Genomics, 1996, Vol. 33 p537-538. |
|
Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, deMartin R. Inhibition of endothelial cell activation by Adenoviris-mediated expression of IkBa, an Inhibitor of the Transcription Factor NF-kB. J Exp Med. 1996, Vol. 183, p1013-1022. |
|
Seiffert D, Curriden SA, Jenne D, Binder BR, Loskutoff DJ. Differential regulation of vitronectin in mice and humans in vitro. J Biol Chem. 1996, Vol. 271(10), p5474-80. |
|
Böhm T, Geiger M, Binder BR. Isolation and characterization of tissue-type plasminogen activator-binding proteoglycans from human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 1996, Vol, 16, p665-672. |
|
Vetr H, Lipp J. Tumor necrosis Factor-Induced expression of porcine glycoproteins GP65 and GP100 recognized by human xenoreactive natural antibodies. Transplantation 1996, Vol. 62, p396-402. |
|
Zoellner H, Bielek E, Vanyek E, Fabry A, Wojta J, Höfler M, Binder BR. Canalicular fragmentation of apoptotic human endothelial cells. Endothelium, 1996, 4 p177-188. |
|
Zhang JC, Fabry A, Paucz L, Wojta J, Binder BR. Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cells. Blood, 1996, Vol. 88(10), p3880-3886. |
|
Zoellner H, Höfler M, Beckmann R, Hufnagl P, Vanyek E, Bielek E, Wojta J, Fabry A, Lockie S, Binder BR. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci. 1996, Vol. 109(10), p2571-2580. |
|
Zehetgruber M, Beckmann R, Gabriel H, Christ G, Binder BR, Huber K. The ACE-Inhibitor Lisinopril affects Plasma insulin levels but not fibrinolytic parameters. Thromb. Res. 1996, Vol. 83(2), p143-152. |
|
Gallicchio M, Hufnagl P, Wojta J, Tipping P. IFN-gamma inhibits Thrombin- and Endotoxin-indiced Plasminogen activator inhibitor Typ 1 in human Endothelial cells. J Immunol. 1996, Vol. 157, p2610-2617. |
|
Zheng X, Zechmeister-Machhart, Uhrin P, Hufnagl P, Geiger M, Binder BR. Effect of Protein C Inhibitor (PCI) on in vitro fertilization. Immunopharmacology, 1996, Vol. 33, p140-142. |
|
Grubic N, Stegnar M, Peternel P, Kaider A, Binder BR. A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis. Throm Res. 1996, Vol. 84(6), p431-443. |
|
Geiger M, Zechmeister-Machhart M, Uhrin P, Hufnagl P, Ecke S, Priglinger U, Xu J, Zheng X and Binder BR: Protein C inhibitor (PCI). Immunopharmacology, 1996 Vol. 32(1-3), p53-56. |
|
Zechmeister-Machhart M, Hufnagl P, Uhrin P, Xu J, Geiger M and Binder BR: Molecular cloning and tissue distribution of mouse protein C inhibitor (PCI). Immunopharmacology 1996 Vol. 32(1-3), p96-98. |
